Combination of Medium Cut-off Dialyzer Membrane and Diet Modification to Alleviate Residual Uremic Syndrome of Dialysis Patients

Last updated: May 17, 2022
Sponsor: University Medical Centre Ljubljana
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04247867
RIIDTOXINS
  • Ages > 18
  • All Genders

Study Summary

The study will compare achieved levels of protein-bound uremic toxins with dialysis using a medium cut-off membrane compared to the treatment by online haemodiafiltration with a high-flux dialysis membrane. In the second phase of the study dietary fiber and short-chain fatty acid intake will be increased to verify a possible additional reduction in the levels of protein bound uremic toxins.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patient on chronic hemodialysis or hemodiafiltration for at least 12 weeks,
  • age 18 years old or more,
  • a functioning arteriovenous fistula or graft as a permanent dialysis vascular access,
  • being able to give an informed consent to participate in the survey;

Exclusion

Exclusion Criteria:

  • planned kidney transplantation, transition to peritoneal dialysis or to anotherdialysis center within 12 weeks of the start of the study,
  • active chronic inflammation (e.g., an active autoimmune disease or an open wound),chronic ongoing infection or cancer in last 4 weeks,
  • acute febrile illness in last 4 weeks,
  • new cardiovascular or neurovascular event in last 4 weeks,
  • a need for hospitalization in the last 4 weeks,
  • clinically evident malnutrition and/or body mass index of 19 kg/m2 and/or loss of bodyweight for 5% in last 3 months,
  • immunosuppressive treatment,
  • expected survival of less than 1 year,
  • pregnancy or breast-feeding,
  • indication for dietary supplements to increase calorie and / or protein intake,
  • specific indication for carrying out hemodiafiltration instead of hemodialysis as perattending physician,
  • serum albumin concentration <32 g/l at screening to enter the study,
  • inability to follow the study diet or test procedures,
  • rapid reduction of residual renal function in the period prior to entry into thestudy,
  • intolerant of on-line haemodiafiltration (infusion intolerance);

Study Design

Total Participants: 50
Study Start date:
August 31, 2020
Estimated Completion Date:
October 31, 2022

Study Description

The investigators will carry out a prospective interventional randomised study to compare achieved serum concentrations of selected protein bound uremic toxins by dialysis with a medium cut-off membrane (Theranova, Baxter AG, USA) and online hemodiafiltration with a standard "high-flux" dialysis membrane. In the second phase, both dialysis purification methods will be supplemented by a change in the diet with increase of the daily intake of dietary fiber to 30g and addition of a short-chain fatty acid propionate in the dose of 1 g daily.

The main outcome of the study is the serum concentration of p-cresol sulphate. Secondary outcome is the serum concentration of indoxyl-sulphate and trimethylamine-N-oxide (TMAO). Serum albumin concentration and lean body weight of patients represent safety outcomes for this study.

This investigator-initiated research project has been entirely planned and will be conducted by the clinical researchers in a tertiary University Medical Center Ljubljana.

The study will include 50 chronic prevalent stable dialysis patients in the following periods:

  • 2 weeks of wash-in period with standard bicarbonate haemodialysis and standard high-flux dialysis membrane,

  • then the patients will be randomized in a 1:1 ratio to either one of the two study arms:

  • (interventional study arm) 4 weeks of dialysis with medium cut-off (Theranova) membrane (first phase), then dialysis for 4 weeks with the same membrane and increased fiber intake (second phase),

  • (control study arm) 4 weeks of dialysis with a high-flux membrane using on-line haemodiafiltration (first phase) and 4 weeks of high-flux membrane haemodiafiltration and increased fiber intake (second phase),

  • finally, all patients will undergo a 4 week wash-out period with a standard bicarbonate haemodialysis using standard high-flux dialysis membrane identical to wash-in period.

Measurement of the study end-points will be carried out at the end of 2-week wash-in period, each 4-week period and at the end of 4 week wash-out period.

Connect with a study center

  • University Medical Center ljubljana

    Ljubljana, 1000
    Slovenia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.